Product Images Losartan Potassium

The text is an identification label or product information for a pharmaceutical drug, specifically for Losartan Potassium 100mg tablets. The label indicates the manufacturer, lot number, National Drug Code (NDC), and expiration date. The label provides warnings to keep the product away from children and store at a controlled temperature. The phone number for medical advice and a label serial number are also provided.*

This is a partial report of a clinical study comparing the effect of Atenolol and Losartan Potassium on patients. It indicates that the adjusted risk reduction for the primary endpoint is 13% with a p-value of 0.021. The data is presented in a graph with the study month ranging from 6 to 66 months.*

This is a table with two medications listed: Atenolol and Losartan Potassium. It appears to be showing the percentage of patients with fatal/non-fatal outcomes for each medication over the course of a study that lasted 66 months. There is also a line that states an adjusted risk reduction of 25% with a p-value of 0.001.*

Figure 3 presents the Primary Endpoint Events within Demographic Subgroups for a study conducted on a population that includes seniors. The data includes results for individuals above 85 years old, broken down by gender and race. There is also information on other factors such as history of VD and levels of potassium and fever.*

This is a statistical data comparison between the Losttan Potassium and Placebo treatments, where 60 patients treated with Losttan Potassium had an event and 40 patients treated with Placebo had an event. The Risk Reduction value is calculated at 16.1% with a significance level of p=0.022. This chart is probably part of a study or analysis of these treatments in a clinical trial.*